DURECT Corporation (DRRX)
USD 0.6
(3.1%)
USD 0.6
(3.1%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -27.62 Million USD | 22.37% |
| 2022 | -35.58 Million USD | 6.66% |
| 2021 | -38.12 Million USD | -1411.7% |
| 2020 | -2.52 Million USD | 88.93% |
| 2019 | -22.78 Million USD | 10.01% |
| 2018 | -25.32 Million USD | -585.3% |
| 2017 | -3.69 Million USD | 89.29% |
| 2016 | -34.5 Million USD | -52.27% |
| 2015 | -22.66 Million USD | -2.5% |
| 2014 | -22.11 Million USD | -3.07% |
| 2013 | -21.45 Million USD | -232.42% |
| 2012 | 16.2 Million USD | 186.33% |
| 2011 | -18.76 Million USD | 18.05% |
| 2010 | -22.89 Million USD | 25.45% |
| 2009 | -30.71 Million USD | 31.82% |
| 2008 | -45.05 Million USD | -85.1% |
| 2007 | -24.33 Million USD | 26.97% |
| 2006 | -33.32 Million USD | -83.84% |
| 2005 | -18.12 Million USD | 34.41% |
| 2004 | -27.63 Million USD | -21.76% |
| 2003 | -22.69 Million USD | 38.94% |
| 2002 | -37.17 Million USD | 17.26% |
| 2001 | -44.92 Million USD | -126.33% |
| 2000 | -19.85 Million USD | -127.96% |
| 1999 | -8.7 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -7.64 Million USD | -430.4% |
| 2024 Q2 | -3.7 Million USD | 51.59% |
| 2023 Q2 | -11.18 Million USD | 8.55% |
| 2023 Q1 | -12.22 Million USD | -29.51% |
| 2023 Q3 | -3.01 Million USD | 73.03% |
| 2023 Q4 | -1.44 Million USD | 52.21% |
| 2023 FY | -27.62 Million USD | 22.37% |
| 2022 Q2 | -12.01 Million USD | -6.17% |
| 2022 FY | -35.58 Million USD | 6.66% |
| 2022 Q3 | -2.81 Million USD | 76.61% |
| 2022 Q4 | -9.44 Million USD | -235.94% |
| 2022 Q1 | -11.31 Million USD | -61.5% |
| 2021 Q2 | -9.14 Million USD | 9.75% |
| 2021 Q4 | -7 Million USD | 29.76% |
| 2021 Q1 | -10.13 Million USD | -332.43% |
| 2021 FY | -38.12 Million USD | -1411.7% |
| 2021 Q3 | -9.97 Million USD | -9.09% |
| 2020 Q3 | -9.33 Million USD | -165.09% |
| 2020 Q4 | 4.36 Million USD | 146.72% |
| 2020 Q1 | -9.94 Million USD | -135.12% |
| 2020 FY | -2.52 Million USD | 88.93% |
| 2020 Q2 | 14.33 Million USD | 244.13% |
| 2019 Q1 | -7.13 Million USD | 2.32% |
| 2019 Q3 | -1.99 Million USD | 72.46% |
| 2019 Q2 | -7.22 Million USD | -1.36% |
| 2019 FY | -22.78 Million USD | 10.01% |
| 2019 Q4 | -4.23 Million USD | -112.61% |
| 2018 Q4 | -7.29 Million USD | -168.84% |
| 2018 FY | -25.32 Million USD | -585.3% |
| 2018 Q3 | -2.71 Million USD | 61.28% |
| 2018 Q2 | -7.01 Million USD | 15.5% |
| 2018 Q1 | -8.29 Million USD | -200.75% |
| 2017 Q4 | 8.23 Million USD | 34.76% |
| 2017 FY | -3.69 Million USD | 89.29% |
| 2017 Q1 | -8.11 Million USD | 7.91% |
| 2017 Q2 | -9.92 Million USD | -22.34% |
| 2017 Q3 | 6.11 Million USD | 161.56% |
| 2016 Q4 | -8.81 Million USD | 0.24% |
| 2016 Q1 | -7.85 Million USD | -34.34% |
| 2016 Q2 | -9.01 Million USD | -14.8% |
| 2016 Q3 | -8.83 Million USD | 2.02% |
| 2016 FY | -34.5 Million USD | -52.27% |
| 2015 Q4 | -5.84 Million USD | 9.9% |
| 2015 Q3 | -6.48 Million USD | -18.42% |
| 2015 Q2 | -5.47 Million USD | -12.88% |
| 2015 Q1 | -4.85 Million USD | 18.3% |
| 2015 FY | -22.66 Million USD | -2.5% |
| 2014 Q3 | -7.09 Million USD | -29.46% |
| 2014 FY | -22.11 Million USD | -3.07% |
| 2014 Q1 | -3.6 Million USD | 29.41% |
| 2014 Q4 | -5.94 Million USD | 16.24% |
| 2014 Q2 | -5.47 Million USD | -52.17% |
| 2013 Q4 | -5.1 Million USD | 15.34% |
| 2013 Q3 | -6.02 Million USD | -17.08% |
| 2013 Q2 | -5.14 Million USD | 0.73% |
| 2013 Q1 | -5.18 Million USD | 5.75% |
| 2013 FY | -21.45 Million USD | -232.42% |
| 2012 FY | 16.2 Million USD | 186.33% |
| 2012 Q1 | 30.82 Million USD | 1541.96% |
| 2012 Q2 | -4.32 Million USD | -114.04% |
| 2012 Q3 | -4.8 Million USD | -10.98% |
| 2012 Q4 | -5.49 Million USD | -14.49% |
| 2011 Q3 | -5.02 Million USD | 4.19% |
| 2011 FY | -18.76 Million USD | 18.05% |
| 2011 Q4 | -2.13 Million USD | 57.45% |
| 2011 Q1 | -6.35 Million USD | -19.58% |
| 2011 Q2 | -5.24 Million USD | 17.49% |
| 2010 Q4 | -5.31 Million USD | -14.4% |
| 2010 Q2 | -6.3 Million USD | 4.78% |
| 2010 Q3 | -4.64 Million USD | 26.34% |
| 2010 Q1 | -6.62 Million USD | 22.85% |
| 2010 FY | -22.89 Million USD | 25.45% |
| 2009 Q2 | -7.5 Million USD | 13.26% |
| 2009 Q3 | -5.53 Million USD | 26.28% |
| 2009 Q4 | -8.58 Million USD | -55.18% |
| 2009 FY | -30.71 Million USD | 31.82% |
| 2009 Q1 | -8.65 Million USD | 52.83% |
| 2008 Q2 | -8.59 Million USD | -10.31% |
| 2008 Q4 | -18.35 Million USD | -100.33% |
| 2008 Q3 | -9.16 Million USD | -6.54% |
| 2008 Q1 | -7.79 Million USD | -8.1% |
| 2008 FY | -45.05 Million USD | -85.1% |
| 2007 Q4 | -7.21 Million USD | 8.51% |
| 2007 Q3 | -7.88 Million USD | -1545.51% |
| 2007 Q1 | -8.76 Million USD | 10.09% |
| 2007 Q2 | -479 Thousand USD | 94.54% |
| 2007 FY | -24.33 Million USD | 26.97% |
| 2006 FY | -33.32 Million USD | -83.84% |
| 2006 Q1 | -6.25 Million USD | -3.59% |
| 2006 Q2 | -8.73 Million USD | -39.58% |
| 2006 Q3 | -8.58 Million USD | 1.74% |
| 2006 Q4 | -9.75 Million USD | -13.61% |
| 2005 Q4 | -6.04 Million USD | -100.56% |
| 2005 Q2 | -3.64 Million USD | 32.78% |
| 2005 FY | -18.12 Million USD | 34.41% |
| 2005 Q1 | -5.42 Million USD | 21.96% |
| 2005 Q3 | -3.01 Million USD | 17.43% |
| 2004 FY | -27.63 Million USD | -21.76% |
| 2004 Q3 | -7.26 Million USD | 2.33% |
| 2004 Q1 | -5.99 Million USD | -13.9% |
| 2004 Q4 | -6.95 Million USD | 4.21% |
| 2004 Q2 | -7.43 Million USD | -24.09% |
| 2003 Q1 | -5.89 Million USD | 30.33% |
| 2003 FY | -22.69 Million USD | 38.94% |
| 2003 Q4 | -5.25 Million USD | 18.21% |
| 2003 Q3 | -6.43 Million USD | -25.68% |
| 2003 Q2 | -5.11 Million USD | 13.19% |
| 2002 Q3 | -9.05 Million USD | 8.72% |
| 2002 Q2 | -9.91 Million USD | -1.7% |
| 2002 Q1 | -9.74 Million USD | 3.34% |
| 2002 FY | -37.17 Million USD | 17.26% |
| 2002 Q4 | -8.45 Million USD | 6.53% |
| 2001 Q4 | -10.08 Million USD | -12.89% |
| 2001 Q3 | -8.93 Million USD | 57.44% |
| 2001 Q2 | -20.99 Million USD | -326.8% |
| 2001 Q1 | -4.91 Million USD | 0.32% |
| 2001 FY | -44.92 Million USD | -126.33% |
| 2000 Q3 | -5.71 Million USD | -24.09% |
| 2000 Q1 | -4.6 Million USD | 0.0% |
| 2000 FY | -19.85 Million USD | -127.96% |
| 2000 Q2 | -4.6 Million USD | 0.0% |
| 2000 Q4 | -4.93 Million USD | 13.62% |
| 1999 FY | -8.7 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 18.77 Million USD | 247.1% |
| Aquestive Therapeutics, Inc. | -7.87 Million USD | -251.004% |
| Collegium Pharmaceutical, Inc. | 48.15 Million USD | 157.365% |
| Cosmos Health Inc. | -18.54 Million USD | -48.975% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -37.725% |
| Esperion Therapeutics, Inc. | -209.24 Million USD | 86.798% |
| Cronos Group Inc. | -73.96 Million USD | 62.652% |
| Incannex Healthcare Limited | -18.45 Million USD | -49.651% |
| Kala Pharmaceuticals, Inc. | -42.19 Million USD | 34.539% |
| Lifecore Biomedical, Inc. | 12.01 Million USD | 329.951% |
| Regencell Bioscience Holdings Limited | -4.3 Million USD | -542.144% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -513.043% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -513.043% |
| SCYNEXIS, Inc. | 67.04 Million USD | 141.205% |
| Safety Shot Inc | -15.08 Million USD | -83.146% |
| Theratechnologies Inc. | -23.95 Million USD | -15.307% |
| Alpha Teknova, Inc. | -36.78 Million USD | 24.894% |
| Universe Pharmaceuticals INC | -6.16 Million USD | -348.219% |
| Pacira BioSciences, Inc. | 41.95 Million USD | 165.842% |
| Sonoma Pharmaceuticals, Inc. | -4.83 Million USD | -471.334% |
| Dynavax Technologies Corporation | -6.38 Million USD | -332.368% |
| Ironwood Pharmaceuticals, Inc. | -1 Billion USD | 97.244% |
| Radius Health, Inc. | -25.79 Million USD | -7.107% |
| China SXT Pharmaceuticals, Inc. | -3.09 Million USD | -791.519% |
| Alvotech | -551.73 Million USD | 94.993% |
| Intra-Cellular Therapies, Inc. | -139.67 Million USD | 80.223% |
| SIGA Technologies, Inc. | 68.06 Million USD | 140.582% |
| Shineco, Inc. | -22.44 Million USD | -23.052% |
| Silver Spike Investment Corp. | 7.34 Million USD | 476.343% |
| Journey Medical Corporation | -3.85 Million USD | -616.948% |
| Petros Pharmaceuticals, Inc. | -8.16 Million USD | -238.397% |
| Embecta Corp. | 70.4 Million USD | 139.239% |
| Harrow Health, Inc. | -24.41 Million USD | -13.162% |
| Procaps Group, S.A. | 42.54 Million USD | 164.937% |
| Biofrontera Inc. | -20.13 Million USD | -37.221% |
| PainReform Ltd. | -9.34 Million USD | -195.634% |
| Supernus Pharmaceuticals, Inc. | 1.31 Million USD | 2199.088% |
| OptiNose, Inc. | -35.48 Million USD | 22.149% |
| RedHill Biopharma Ltd. | 23.91 Million USD | 215.504% |
| Organogenesis Holdings Inc. | 4.94 Million USD | 658.625% |
| Cumberland Pharmaceuticals Inc. | -6.27 Million USD | -339.92% |
| ProPhase Labs, Inc. | -16.78 Million USD | -64.605% |
| Phibro Animal Health Corporation | 2.41 Million USD | 1243.377% |
| Procaps Group S.A. | 42.54 Million USD | 164.937% |
| TherapeuticsMD, Inc. | -10.27 Million USD | -168.768% |
| Viatris Inc. | 54.7 Million USD | 150.501% |
| Rockwell Medical, Inc. | -8.43 Million USD | -227.337% |
| Aytu BioPharma, Inc. | -15.84 Million USD | -74.35% |
| Tilray Brands, Inc. | -244.98 Million USD | 88.724% |
| PetIQ, Inc. | 2.13 Million USD | 1396.293% |
| Talphera, Inc. | -18.39 Million USD | -50.155% |
| Neurocrine Biosciences, Inc. | 249.7 Million USD | 111.063% |
| Alimera Sciences, Inc. | -20.13 Million USD | -37.214% |
| Assertio Holdings, Inc. | -331.94 Million USD | 91.678% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6.59 Million USD | -319.007% |
| Avadel Pharmaceuticals plc | -160.27 Million USD | 82.765% |
| Hempacco Co., Inc. | -13.12 Million USD | -110.451% |
| Alvotech | -551.73 Million USD | 94.993% |
| Lantheus Holdings, Inc. | 326.66 Million USD | 108.456% |
| Kamada Ltd. | 8.28 Million USD | 433.462% |
| Currenc Group, Inc. | -15.3 Million USD | -80.472% |
| Indivior PLC | 2 Million USD | 1481.2% |
| Evoke Pharma, Inc. | -7.79 Million USD | -254.504% |
| Flora Growth Corp. | -57.03 Million USD | 51.567% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -37.725% |
| Evolus, Inc. | -61.68 Million USD | 55.218% |
| HUTCHMED (China) Limited | 100.78 Million USD | 127.41% |
| Amphastar Pharmaceuticals, Inc. | 137.54 Million USD | 120.084% |
| Akanda Corp. | -32.27 Million USD | 14.411% |